SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

29 Jan 2024 Evaluate
A fair growth of 24.41% in the revenue at Rs. 109.42 millions was reported in the December 2023 quarter as compared to Rs. 87.95 millions during year-ago period.The Net Profit of the company reported a remarkable increase of 143.20% to Rs. 33.61  millions  from Rs. 13.82 millions in previous same quarter.Operating Profit saw a handsome growth to 55.48 millions from 37.36 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 109.42 87.95 24.41 317.26 314.51 0.87 424.24 365.65 16.02
Other Income 2.84 1.63 74.23 6.78 8.58 -20.98 10.84 6.29 72.34
PBIDT 55.48 37.36 48.50 151.19 165.28 -8.52 217.87 180.90 20.44
Interest 0.00 0.00 0.00 0.00 1.12 0.00 1.12 12.15 -90.78
PBDT 55.48 37.36 48.50 151.19 164.16 -7.90 216.75 168.75 28.44
Depreciation 17.44 18.05 -3.38 53.52 53.96 -0.82 71.73 69.74 2.85
PBT 38.04 19.31 97.00 97.67 110.20 -11.37 145.02 99.01 46.47
TAX 4.43 5.49 -19.31 21.29 31.01 -31.34 29.17 -122.75 -123.76
Deferred Tax 4.43 5.49 -19.31 21.29 31.01 -31.34 29.17 -122.75 -123.76
PAT 33.61 13.82 143.20 76.38 79.19 -3.55 115.85 221.76 -47.76
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 50.70 42.48 19.36 47.65 52.55 -9.32 51.36 49.47 3.80

Zenotech Laboratorie Share Price

49.39 1.38 (2.87%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×